Recent studies have evaluated the relationship between adiponectin levels and some liver diseases, such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), hepatic fibrosis, and hepatocellular carcinoma (HCC). Here, ADIPOQ is linked to Hepatic fibrosis.